Here's the thing. Generex / NGIO is in a unique p
Post# of 36566
(Total Views: 272)
Posted On: 07/14/2020 12:12:30 PM
Here's the thing. Generex / NGIO is in a unique position. They are working on a Covid19 vaccine, a cancer drug and have the potential of working on the Swine flu that is now rearing its head in China.
I hope Joe signed the papers concerning the agreement with OASIS and NGIO is now able to tap into the 50 million dollars. Having that access will allow them to be able to get their 'pandemic research' up and running and make them a premier company to handle these problems which seem to be popping up now.
Maybe, just maybe, a decent PR will come out announcing all of this, showing what is going on, the final signing, the now money available, the full steam ahead that will really excite the masses, we need something.
Generex / NGIO has so much potential it is just frustrating to see it wallowing right now and to see it wallowing for so long. They have top notch researchers, top notch science, products that can help people, The PPS is a sham. The companies are worth far more than what the PPS shows and I am hopeful that soon, that will be proven.
Rant over.
I hope Joe signed the papers concerning the agreement with OASIS and NGIO is now able to tap into the 50 million dollars. Having that access will allow them to be able to get their 'pandemic research' up and running and make them a premier company to handle these problems which seem to be popping up now.
Maybe, just maybe, a decent PR will come out announcing all of this, showing what is going on, the final signing, the now money available, the full steam ahead that will really excite the masses, we need something.
Generex / NGIO has so much potential it is just frustrating to see it wallowing right now and to see it wallowing for so long. They have top notch researchers, top notch science, products that can help people, The PPS is a sham. The companies are worth far more than what the PPS shows and I am hopeful that soon, that will be proven.
Rant over.
(1)
(0)